PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) Net margin 2022–2025
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) net profit margin by fiscal year — reported net income divided by reported revenue.
1637.9%FY2025 · since FY2022: -359.4% → 1637.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 1637.9% | +866.3 pp |
| FY2024 | 771.6% | +215.5 pp |
| FY2023 | 556.2% | +915.6 pp |
| FY2022 | -359.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice